Chordoma research is led by a comprehensive team including Gary Gallia, M.D., director of the Neurosurgery Skull Base Tumor Center. The laboratory focuses on developing new therapies for brain and skull base tumors, and has established the first primary skull base chordoma xenograft mouse model. The team is also exploring high throughput drug screening using the chordoma model, and the molecular pathways responsible for tumor maintenance and growth.
The Spinal Research Laboratory is the world’s leading research lab dedicated to animal models of spinal conditions. Our goal is to improve care and surgical outcomes for patients with spinal problems. Using novel models and techniques, our investigators have created new ways to study tumors of the spinal cord and spinal column, spinal paralysis and spinal fusion physiology. In addition, they consistently test spinal devices for effectiveness.